and insulin insensitivity compared with the first trimester microbiota. These findings suggest that microbiota changes over pregnancy may facilitate the metabolic alterations observed in late gestation. Most women in the above-mentioned Finnish study were White and had a pre-pregnancy body mass index (BMI) < 25 kg/m 2 (58%), and therefore are not likely generalizable to U.S. women. The objective of our study was twofold: (1) to define maternal gut microbiome in a diverse population of U.S. women by gestational age and race and (2) to examine correlation between maternal gut microbiome changes over pregnancy with maternal (obesity and antibiotic use) and clinical gestational weight gain (GWG) and infant birth weight characteristics.
Materials and Methods

Study Participants and Specimen Collection
This study was conducted in two phases. In phase 1, our objective was to define the maternal gut microbiota at the phylum level in our obstetric population. We conducted a cross-sectional study of 20 nondiabetic pregnant women enrolled between 14 and 28 weeks of gestation. Race was self-reported. Maternal fecal samples were collected by inserting two sterile Dacron swabs 1 to 2 inches into the rectum and held for 15 to 20 seconds. The primary outcome for phase I was description of microbiota at the phylum levels at early (14-21 weeks) and late (22-28 weeks) second trimester gestational age and by maternal race. The purpose of phase 2 was to assess the change in maternal microbiome over pregnancy in our obstetrics population. We conducted a longitudinal study of 31 pregnant women enrolled for the first study visit at less than 20 weeks of gestation (baseline) with a second study visit at 36 to 39 weeks of gestation (follow-up). We excluded women with any condition associated with immunosuppression (e.g., pre-existing diabetes, HIV/AIDS, inflammatory bowel disease, end-stage renal disease, Crohn's disease, etc) or taking immunosuppressive medications (e.g., daily corticosteroids, immunomodulators). Maternal rectal swab samples were collected at both study visits. In phase 2, we excluded women from the analysis for whom we did not obtain a follow-up sample because they delivered preterm prior to sample collection (n ¼ 7), had a second trimester miscarriage (n ¼ 1), or transferred to another facility (n ¼ 2). The primary outcome for phase II was phylum and genus level microbiota change over two collection time points, baseline and follow-up. We assessed phylum and genus level microbiota change by race/ethnicity, which was self-reported. Because the majority of our population was White women, we assessed the change of phylum and genus level change over gestational age only among White women. We also assessed the change in phylum and genus level microbiota abundance in those who gained above and below the median gestational weight gain (GWG) for this cohort, early pregnancy obesity (defined as maternal BMI ! 30 kg/m 2 at first visit), antibiotic exposure during pregnancy, and infant birth weight among singleton gestation. We described the α diversity, the number of sequences in a sample; richness, the number of species present in a sample; and evenness, the relative abundance of different species that make up the richness in a sample. This study was reviewed and approved by UNC-Chapel Hill School of Medicine Institutional Review Board.
Microbiota Analysis
DNA Extraction
Rectal swabs were placed into a cryogenic vial containing phosphate buffered saline (PBS) and were stored (immediately or within 60-minute timeframe) at À 80°C. Prior to DNA extraction, the cryogenic vial containing the swab was thawed to room temperature and vortexed for 60 seconds to release all cells from the swab. DNA extraction was performed on the bacterial cells from the swabs using a modified protocol of the DNeasy Blood and Tissue kit (Qiagen). Cells suspended in PBS were pelleted down by centrifugation, and the supernatant was removed followed by the addition of lysozyme (20 mg/mL), mutanolysin (25 KU/mL), and kit buffer (ATL) and incubated at 37°C for 30 minutes. After incubation, proteinase K was added and the samples were incubated at 56°C overnight. Bead beating was performed on the samples using 0.5-mm stainless steel beads in a Bullet Blender (Next Advance, Averill Park, NY). The supernatant was removed from the beads and used to perform the remainder of the extraction according to kit protocol.
Ion Torrent Library Preparation and Sequencing
For amplicon library preparation, we used fusion primers comprising Ion Torrent adapter. These included 5′-CCA TCTCATCCCTGCGTGTCTCCGACTCAG -3′ (forward primer), 5′-CCTCTCTATGGGCAGTCGGTGAT-3′ (reverse primer), and universal bacterial primers, 8F: 5′-AGAGTTTGATCCTGGCTCAG-3′ and 338R: 5′-GCTGCCTCCCGTAGGAGT-3′. The forward primer also included a 10 bp Ion Xpress barcode, unique to each sample. Each bacterial DNA sample was run in duplicate in a 25 µL PCR reaction containing 4 µL of 5 Â MyTaq Reaction Buffer (Bioline, London, United Kingdom); 0.6 µL each of 15 µM forward primer and 15 µM reverse primer (Integrated DNA Technologies, Coralville, IA); 0.5 µL MyTaq HS DNA Polymerase (Bioline); and 100 ng template DNA. Water was used to make up the volume to 25 µL. Samples were denatured at 94°C for 5 minutes, followed by 35 cycles of 94°C for 45 seconds, 55°C for 45 seconds, and 72°C for 90 seconds, followed by an extension at 72°C for 10 minutes and a 4°C hold. PCR visualization and purification were combined into a single step using the E-Gel Electrophoresis System and an E-Gel SizeSelect 2% agarose gel (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Samples were quantified using an Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA). The purified PCR product was then combined in equimolar amount concentration to create a library. The library was sequenced on the Ion Torrent Personal Genome Machine (PGM) instrument (Life Technologies, Carlsbad, CA) according to the manufacturer's protocol.
16S rRNA Sequence Analysis and Statistical Analysis
The bacterial 16S rRNA sequences of V4 region were processed to remove low-quality reads and analyzed in QIIME. 8 Sequences were assigned to operational taxonomic units (OTUs) using the Greengenes database. 9 The number of sequences assigned to each OTU was used to generate a data matrix that was used for downstream multivariate and microbiota diversity analyses. Raw counts were standardized, transformed (log (X þ 1)), and used to build a resemblance matrix. We performed cluster analysis using PRIMER 7 (Lutton, Ivybridge, United Kingdom) to determine whether bacterial profiles differed by gestational age and longitudinally through pregnancy at two time points. Differentially abundant taxa between groups or time points were identified using Metastats, which included correction for multiple testing. 10 A corrected p-value < 0.05 was considered statistically significant.
Results
In phase 22-36), median gestational weight gain (GWG) was 15.4 kg (IQR: 17.5-37.5), and median infant birth weight for singletons was 3,291 g (IQR: 2,505-4,077). Three women had twin pregnancies. Ten women (32%) reported having infections during pregnancy (urinary tract infection, pyelonephritis, gastroenteritis, influenza, chlamydiasis), and nine of these women received antibiotics during pregnancy. We enrolled women in early gestation and did not exclude women based on antibiotic use. While women did not collect a diet history, one woman reported a lacto-ovo vegetarian diet. None of the women used probiotics supplements during their pregnancy. Eleven women (35%) had paired samples (baseline and follow-up) available for analysis (►Table 1). A total of 20 women (65%) had one sample available for analysis (6 baseline and 14 follow-up).
Matched Samples
Among the 11 paired samples, 5 distinct phyla were observed (Bacteroidetes, 30%; Firmicutes, 37%; Proteobacteria, 18%; Actinobacteria, 9%; Fusobacteria, 3%; and other, 3%). The "other" category consisted of phyla that contributed < 1% of the overall bacterial abundance, namely, Acidobacteria, Cyanobacteria, Spirochaetes, Synergistetes, Tenericutes, and Verrucomicrobia. At the phylum level, there was no difference in overall richness at baseline compared with follow-up (d ¼ 2.07 AE 0.09 vs. and follow-up samples, there was an increase in the relative abundance of Actinobacteria, Proteobacteria, and Fusobacteria and a decrease in relative abundance of Bacteroidetes and Firmicutes, although these trends were not statistically significant (►Table 3).
There were also significant differences in the relative abundance of several taxa between baseline and follow-up, including Actinomyces (phylum: Actinobacteria), Finegoldia (phylum: Firmicutes), Anaerococcus (phylum: Firmicutes), and Eggerthella (phylum: Firmicutes, ►Table 4). Some taxa, such as Acidaminococcus (phylum: Firmicutes), Pseudomonas (phylum: Proteobacteria), and Ralstonia (phylum: Proteobacteria) were absent at baseline but markedly present at follow-up.
Maternal and Clinical Characteristics
Race
Compared with White women, non-White women had a decrease in relative abundance of Proteobacteria (22 AE 0.34 vs.
7.5% AE 0.29, p ¼ 0.01). While not statistically significant, the relative increase in Fusobacteria among non-White women (9%) compared with White women (0.3%) seemed to account for this relative change in abundance.
Because the majority of women in our paired samples were White (n ¼ 8, 72%), we analyzed the change in gestational age only among White women. There were no significant differences between baseline and follow-up period at the phylum level. However, at the genus level, there were significant differences including Anaerococcus (phylum: Firmicutes), Butryricimonas (phylum: Bacteroides), Eggerthella (phylum: Actinobacteria), Finegoldia (phylum: Firmicutes), Propionibacterium (phylum: Firmicutes), Pseudomonas (phylum: Proteobacteria), Roseburia (phylum: Firmicutes) Shewanella (phylum: Proteobacteria) and Tepidimonas (phylum: Proteobacteria; all p < 0.05; ►Fig. 1). Most notably, Roseburia had a 10-fold reduction from 53% relative abundance at baseline to 5.9% (p ¼ 0.027).
Gestational Weight Gain
We assessed microbiome change among women who gained weight above or below the median GWG for our sample (15.4 kg). Compared with those who gained weight below the median GWG, women who gained above the median GWG had increased relative abundance of Bacteroidetes (p ¼ 0.02) and other phyla (p ¼ 0.04) from baseline to follow-up. While the difference in Fusobacteria abundance was not statistically significant, this phylum was only observed in 0.3% of women with less than the median GWG compared with 5% of women above the median GWG (p ¼ 0.14). For women who gained weight above median GWG, there was increased bacterial diversity (p ¼ 0.04) compared with those who gained less than the median GWG.
Maternal Obesity
When we compared obese and nonobese women at baseline, there was no difference between relative abundance of 
Infant Birth Weight
We assessed results for all samples (n ¼ 28) from singleton pregnancies to evaluate the relationship between mother's microbiome and infant birth weight. Median infant birth weight among singletons was 3,291 g (IQR: 2,505-4,077). There was also moderate correlation between infant birth weight and Proteobacteria abundance (correlation coefficient [r] ¼ 0.4, p ¼ 0.04) and a strong negative correlation with the bacteria in the "other" category (r ¼ À 0.6, p ¼ 0.001; ►Fig. 2).
Antibiotic Use
When comparing matched samples for women who received antibiotics for infections during pregnancy, there were three samples for women who received antibiotics and eight samples of women who did not. Women who received antibiotics had a relative decrease in abundance in Bacteroidetes compared with women who did not receive antibiotics (25 AE 0.21 vs. 31% AE 0.21, p < 0.001; ►Table 5).
Discussion
Our study found that maternal gut microbiome changes over gestation in a population of diverse U.S. women. Over the course of a pregnancy, richness decreased and diversity and evenness increased from early pregnancy ( 20 weeks) to late third trimester, similar to the findings of Koren et al. 7 Women who gained weight above the median GWG had an increase in bacterial diversity compared with those who gained less than the median GWG. In the entire cohort, some taxa were absent at baseline but markedly present at follow-up, suggesting that the bacterial shifts were associated with changes in gestational age. Our results indicate that gut microbiome is dynamic between and among pregnant women and correlates with clinically important characteristics, including race, maternal obesity, GWG, and infant birth weight. Our study corroborates the findings of others that the maternal gut microbiome shifts over the course of pregnancy; however, whether these changes reflect normal physiological change or dysbiosis leading to adverse outcomes remains unknown. To date, we have contradictory information regarding changes in the microbiome during pregnancy. Koren et al observed increased abundance of Proteobacteria and Actinobacteria from trimester one to trimester three. 7 In our phase 1 results, we found that Proteobacteria correlated with earlier gestation ( 21 weeks) and Black race. In our phase 2 results, we found that Proteobacteria were not different between baseline and follow-up. In phase 2, we found an increase in Actinobacteria between the time points but results did not reach statistical significance. In the study by Koren et al, Proteobacteria were associated with increased inflammatory markers. While we did not assess markers of inflammation in our study, in studies of nonpregnant individuals, high abundance of Proteobacteria has been associated with individuals with gastrointestinal disease compared with healthy individuals.
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Fig . 2 Correlation between singleton infant weight and relative abundance of bacteria at phylum level (n ¼ 24). In pregnancy, both Black race and early gestation are associated with increased proinflammatory states, 13 a potential explanation for the increased abundance of Proteobacteria in our study. Our study did not find a correlation between maternal obesity and relative abundance of bacteria. In contrast, Collado et al found that overweight pregnant women had significantly higher levels of Bacteroides and Staphylococcus, while Santacruz et al detected an increase in Staphylococcus in overweight pregnant women and a decrease in Bifidobacterium (phylum: Actinobacteria) and Bacteroides (phylum: Bacteroidetes).
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Currently, the available literature regarding the maternal gut microbiome is contradictory. Conclusions about the normal or abnormal constitution or changes over pregnancy are premature.
Our study faced many challenges. In our study, 80% of rectal samples had detectable DNA. We attributed the lack of results in 20% of our samples to our technique of using rectal swabs as opposed to fecal samples, which have been used by others. 7, 14, 15 This may have impacted our ability to obtain detectable DNA in some samples. We chose to use rectal swabs, as we could obtain them directly in clinic and not rely on women providing a stool sample. We believe that the smaller amount of fecal material obtained using a rectal swab as opposed to a fecal sample probably explains the relatively high proportion of women with samples that had undetectable DNA on rectal swab. Another possible explanation for the frequency of undetectable DNA is the presence of PCR inhibitors preventing the sample from amplifying.
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In designing studies of future gut microbiome in pregnancy, researchers should be aware that rectal swab technique may lead to a relatively high percentage of women providing samples that yield no usable data. Only one woman in our cohort had gestational diabetes (GDM). In the study by Koren et al, women with GDM had a diminished microbial richness compared with those without GDM, although the microbiota did not differ significantly in composition. Our most significant limitation was the relatively small number of women in our matched sample. One of our primary objectives was to define maternal gut microbiome in a diverse population of U.S. women race. Of our 20 participants, 70% selfidentified as White. While we did detect a difference in relative abundance of Proteobacteria between White and non-White women, we were underpowered to detect other differences in gut microbiome composition; thus, these results should be interpreted with caution. We were also limited in our ability to assess if race was a confounder in our analysis of obesity. As described in our results, we found no significant difference among women with BMI ! 30 kg/m 2 . We lacked sufficient sample size to examine class 3 obesity (BMI ! 40 kg/m 2 ). Future directions for studies of maternal microbiome with larger sample size could address if race and obesity are confounders of maternal microbiome changes. Based on the results of this pilot study, we suggest that larger studies of racially and ethnically diverse pregnant women are needed to characterize the inter-and intraracial and ethnic gut microbiome variability. Because of our relatively small sample size, we may be underpowered to detect differences at the phylum level; however, we were able to detect differences at the genus level. We also did not collect detailed dietary logs. While no women reported highly restrictive diets, we did not have detailed dietary data. Diet is known to rapidly affect gut microbiome. 18, 19 Because of our small sample size, we were also not able to assess differences that could be attributable to seasonal variations. 20 While we did assess the effect of antibiotic use in pregnancy, our sample size was small, and these results were intended to provide exploratory data. Approximately 30% of pregnant women receive a course of antibiotics during pregnancy; 21 future studies should also explore the impact of antibiotics on maternal microbiome. In our cohort, the median GWG was 15.4 kg, which corresponded to the high GWG group (16 kg) in Cedergren's studyone of the key studies correlating adverse maternal and fetal outcomes with GWG. 22 Importantly, high GWG does not only affect obese women. In fact, the relative risk of large for gestational age (LGA) infants and cesarean delivery is higher among women with nonobese prepregnancy BMI. 21 Reducing fetal overgrowth among obese and nonobese pregnant women could both lessen the immediate infant delivery complications and mitigate the intergenerational transmission of obesity. There are knowledge gaps whether optimization of maternal gut microbiome can improve pregnancy outcomes. In pregnancy, there is significant inter-and intraindividual gut microbiota variability, particularly at the genus level. Our study did not find a change in the Bacteroidetes and Firmicutes phyla, but there was significantly higher contribution of Proteobacteria in early second trimester and higher contribution of Fusobacteria in late second trimester. Compared with White women, there was a higher proportion of Firmicutes among non-White pregnant women. While we were able to correlate changes in maternal microbiome abundance with GWG, infant weight, and BMI, the full impact of microbiome diversity on maternal and infant outcomes is unknown. Manipulation of maternal gut microbiota could represent an innovative strategy to optimize gestational weight gain and maternal and fetal outcomes; however, more data are required to assess if pregnancy itself accounts for the changes observed in microbiome and whether these changes are physiological or pathological. We suggest that larger studies of U.S. women are needed to fully characterize the maternal gut microbiome by maternal characteristics, including race, pre-pregnancy BMI, and antibiotic use during pregnancy and assess if changes over time correlate with pregnancy outcomes. Once maternal gut microbiome change is better understood, we propose that potential interventional trials for probiotic and/or prebiotic supplementation and/or diet alterations can be properly designed and conducted.
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